Skip to main content
. 2020 Mar 13;33(5):292–298. doi: 10.1016/j.sdentj.2020.03.003

Table 2.

Risedronate release proportion with and without hydrogel carrier.

Duration (hour) Release Proportion (mean percentage ± SD)
Pure-250 Pure-500 Bis-CR250 Bis-CR500
0 0.199 ± 0.007 0.399 ± 0.014 No release No release
1 0.199 ± 0.006 0.397 ± 0.006 0.157 ± 0.012 0.223 ± 0.011
3 0.070 ± 0.001 0.161 ± 0.053 0.094 ± 0.003 0.115 ± 0.005
6 0.024 ± 0.001 0.047 ± 0.002 0.052 ± 0.002 0.058 ± 0.004
24 0.006 ± 0.001 0.015 ± 0.001 0.234 ± 0.022 0.205 ± 0.013

*All experimental groups were done in triplicate.